Assisted Reproductive Technology in Japan: A Summary Report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and Gynecology
Assisted Reproductive Technology in Japan: Ein Übersichtsbericht für 2023 des Committee on Professional Scientific Conduct and Clinical Ethics der Japan Society of Obstetrics and Gynecology
Reproductive Medicine and Biology · 2026-01 · 25 (1)
DOI: 10.1002/rmb2.70008 ↗Auf einen Blick
2023 wurden in Japan 561 664 ART-Zyklen und 85 048 Neugeborene registriert. Die Zahlen stiegen gegenüber 2022 um 3,3 % bzw. 10,2 %.
Fragestellung
ART-Daten für 2023 aus dem Register der Japan Society of Obstetrics and Gynecology zusammenfassen.
Methode
Registerauswertung auf Basis der ART-Daten 2023 der Japan Society of Obstetrics and Gynecology.
Ergebnisse
625 von 638 registrierten ART-Zentren nahmen teil. Durchschnittsalter 37,3 Jahre; 205 986 Zyklen (36,7 %) bei Frauen ≥ 40 Jahre. SET 80,5 %, Einlingsgeburt 96,5 %; bei Frozen–thawed embryo transfer 271 361 Zyklen, 109 850 Schwangerschaften, 80 774 Neugeborene.
Schlussfolgerung der Autor:innen
2023, das zweite Jahr der Versicherungsdeckung, wurden die höchsten Zahlen an Behandlungszyklen und Neugeborenen registriert. Ein geplantes effektiveres Registersystem ab 2026 soll Trends umfassender bewerten können.
Kernaussagen
- 561 664 ART-Zyklen und 85 048 Neugeborene im Jahr 2023
- Durchschnittsalter 37,3 Jahre; 36,7 % der Zyklen bei Frauen ≥ 40 Jahre
- SET 80,5 %; Einlingsgeburten 96,5 %
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Medicine and Biology, online erschienen am 23.12.2025. Verfasst von Yukiko Katagiri und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine Toho University Tokyo Japan. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Ethik in der Pflege
Abstract (Originalsprache)
Purpose
To summarize assisted reproductive technology (ART) data for 2023 collected through the Japan Society of Obstetrics and Gynecology registry. Methods and Results 625 out of 638 registered ART facilities took part in the study, documenting 561 664 treatment cycles and 85 048 newborns (+3.3% and +10.2% increases from 2022). The average age of women undergoing treatment was 37.3 years (standard deviation: 4.8); 205 986 cycles (36.7%) involved women aged ≥ 40 years. Among fresh cycles, oocyte retrieval was performed in 281 665 cycles, including 168 343 freeze‐all cycles (59.8%). A total of 2329 pregnancies and 3375 newborns resulted from in vitro fertilization and intracytoplasmic sperm injection cycles, yielding 1772 and 2502 newborns, respectively. The overall rates for single embryo transfer (SET) and singleton delivery were 80.5% and 96.5%. Frozen–thawed embryo transfer accounted for 271 361 cycles, resulting in 109 850 pregnancies and 80 774 newborns, with a SET rate of 84.7% and a singleton delivery rate of 96.3%.
Conclusions
In 2023, the second year of insurance coverage, the registry recorded the highest numbers of treatment cycles and newborns. Effective registry systems planned for 2026 will enable comprehensive evaluation of emerging trends in Japanese ART practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Faculty of Medicine Toho University Tokyo Japan.
- Department of Obstetrics and Gynecology Jichi Medical University Tochigi Japan.
- Department of Obstetrics and Gynecology, Graduate School of Biomedical Sciences Tokushima University Tokushima Japan.
- Department of Obstetrics and Gynecology Tokyo Medical University Tokyo Japan.
- Kato Ladies Clinic Tokyo Japan.
- Department of Obstetrics and Gynecology The Jikei University School of Medicine Tokyo Japan.
ORCID-Profile: Hiroshi Kishi, Yoshimitsu Kuwabara, Fuminori Taniguchi
Zitieren
APA
Katagiri, Y., Jwa, S. C., Kuwahara, A., Iwasa, T., Ono, M., Kato, K., Kishi, H., Kuwabara, Y., Taniguchi, F., Harada, M., Iwase, A., & Sugino, N. (2026). Assisted Reproductive Technology in Japan: A Summary Report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and Gynecology. Reproductive Medicine and Biology, 25(1). https://doi.org/10.1002/rmb2.70008
Vancouver
Katagiri Y, Jwa SC, Kuwahara A, Iwasa T, Ono M, Kato K, et al. Assisted Reproductive Technology in Japan: A Summary Report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and Gynecology. Reproductive Medicine and Biology. 2026;25(1). doi:10.1002/rmb2.70008
BibTeX
@article{Katagiri2026,
author = {Katagiri, Yukiko and Jwa, Seung Chik and Kuwahara, Akira and Iwasa, Takeshi and Ono, Masanori and Kato, Keiichi and Kishi, Hiroshi and Kuwabara, Yoshimitsu and Taniguchi, Fuminori and Harada, Miyuki and Iwase, Akira and Sugino, Norihiro},
title = {Assisted Reproductive Technology in Japan: A Summary Report for 2023 by the Committee on Professional Scientific Conduct and Clinical Ethics of the Japan Society of Obstetrics and Gynecology},
journal = {Reproductive Medicine and Biology},
year = {2026},
volume = {25},
number = {1},
doi = {10.1002/rmb2.70008}
}
EUVIMED